NEW YORK, April 2, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Analysis of the United States Bone Grafts and Bone Graft Substitutes Market
This research service considers products and companies in the bone grafts and bone graft substitutes market in the United States. This market expects to witness many technology advancements in the next decade. A thorough analysis of revenue forecasts, unit forecasts, technological advances, and pricing are provided for the market's various segments including: machine allografts, standard allografts, demineralized bone matrix, bone morphogenetic proteins (BMP), bone graft substitutes, and platelet concentration systems markets. Market engineering measurements, drivers, and restraints are covered along with an analysis of the market's highly competitive landscape. The base year is 2011; the forecast period extends through 2016.
•Total revenue generated by sales of bone grafts and bone graft substitutes in the United States (U.S.) in 2011 was approximately $xxmillion, representing a xx percent decrease over 2010.
•Revenue in the U.S. bone grafts and bone graft substitute market is projected to grow at a compound annual growth rate (CAGR) ofxx percent from 2011 to 2016, reaching $xx million in 2016.
•The segment with the highest CAGR is the cell-based matrices market, followed closely by the demineralized bone matrix (DBM) market.
•The decrease in the growth rate for the bone morphogenetic protein (BMP) market has been one of the biggest factors leading to the decline in the overall market. This is the largest segment in the entire market.
•As new clinical data is published and innovation continues, the market is expected to slowly get back to larger market growth numbers.
•The market is mostly controlled by large manufacturers, but there are low barriers to entries in the niche segments.
TABLE OF CONTENTS
Executive Summary 4
Market Overview 9
Total Bone Grafts and Bone Graft Substitutes Market -
•External Challenges: Drivers and Restraints 19
•Forecast and Trends 28
•Competitive Analysis 36
Machined Bone Allograft Segment Breakdown 41
Standard Bone Allograft Segment Breakdown 52
DBM Segment Breakdown 63
Bone Graft Substitutes Segment Breakdown 75
BMP Segment Breakdown 91
Cell-based Matrices Segment Breakdown 104
Platelet Concentration System Segment Breakdown 116
The Last Word (Conclusions and Implications) 127
To order this report:
: Analysis of the United States Bone Grafts and Bone Graft Substitutes Market
Contact Clare: firstname.lastname@example.org
US:(339) 368 6001
Intl:+1 339 368 6001